BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang J, Su G, Yin X, Luo J, Gu R, Wang S, Feng J, Chen B. Non-small cell lung cancer-targeted, redox-sensitive lipid-polymer hybrid nanoparticles for the delivery of a second-generation irreversible epidermal growth factor inhibitor-Afatinib: In vitro and in vivo evaluation. Biomed Pharmacother 2019;120:109493. [PMID: 31586902 DOI: 10.1016/j.biopha.2019.109493] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 4.7] [Reference Citation Analysis]
Number Citing Articles
1 Yadav P, Jain J, Sherje AP. Recent advances in nanocarriers-based drug delivery for cancer therapeutics: A review. Reactive and Functional Polymers 2021;165:104970. [DOI: 10.1016/j.reactfunctpolym.2021.104970] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Hani U, M. YB, Wahab S, Siddiqua A, Osmani RAM, Rahamathulla M. A Comprehensive Review of Current Perspectives on Novel Drug Delivery Systems and Approaches for Lung Cancer Management. J Pharm Innov. [DOI: 10.1007/s12247-021-09582-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Viswanadh MK, Agrawal N, Azad S, Jha A, Poddar S, Mahto SK, Muthu MS. Novel redox-sensitive thiolated TPGS based nanoparticles for EGFR targeted lung cancer therapy. Int J Pharm 2021;602:120652. [PMID: 33915187 DOI: 10.1016/j.ijpharm.2021.120652] [Reference Citation Analysis]
4 Tariq H, Bokhari SAI. Surface-functionalised hybrid nanoparticles for targeted treatment of cancer. IET Nanobiotechnol 2020;14:537-47. [PMID: 33010128 DOI: 10.1049/iet-nbt.2020.0073] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Ghosh S, Javia A, Shetty S, Bardoliwala D, Maiti K, Banerjee S, Khopade A, Misra A, Sawant K, Bhowmick S. Triple negative breast cancer and non-small cell lung cancer: Clinical challenges and nano-formulation approaches. J Control Release 2021;337:27-58. [PMID: 34273417 DOI: 10.1016/j.jconrel.2021.07.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Loo YS, Zahid NI, Madheswaran T, Mat Azmi ID. Recent advances in the development of multifunctional lipid-based nanoparticles for co-delivery, combination treatment strategies, and theranostics in breast and lung cancer. Journal of Drug Delivery Science and Technology 2022;71:103300. [DOI: 10.1016/j.jddst.2022.103300] [Reference Citation Analysis]
7 Mohanty A, Uthaman S, Park IK. Utilization of Polymer-Lipid Hybrid Nanoparticles for Targeted Anti-Cancer Therapy. Molecules 2020;25:E4377. [PMID: 32977707 DOI: 10.3390/molecules25194377] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
8 Wu R, Zhang Z, Wang B, Chen G, Zhang Y, Deng H, Tang Z, Mao J, Wang L. Combination Chemotherapy of Lung Cancer - Co-Delivery of Docetaxel Prodrug and Cisplatin Using Aptamer-Decorated Lipid-Polymer Hybrid Nanoparticles. Drug Des Devel Ther 2020;14:2249-61. [PMID: 32606595 DOI: 10.2147/DDDT.S246574] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
9 Mao K, Zhang W, Yu L, Yu Y, Liu H, Zhang X. Transferrin-Decorated Protein-Lipid Hybrid Nanoparticle Efficiently Delivers Cisplatin and Docetaxel for Targeted Lung Cancer Treatment. Drug Des Devel Ther 2021;15:3475-86. [PMID: 34413632 DOI: 10.2147/DDDT.S296253] [Reference Citation Analysis]
10 Doroudian M, Azhdari MH, Goodarzi N, O'Sullivan D, Donnelly SC. Smart Nanotherapeutics and Lung Cancer. Pharmaceutics 2021;13:1972. [PMID: 34834387 DOI: 10.3390/pharmaceutics13111972] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Chen Y, Deng Y, Zhu C, Xiang C. Anti prostate cancer therapy: Aptamer-functionalized, curcumin and cabazitaxel co-delivered, tumor targeted lipid-polymer hybrid nanoparticles. Biomed Pharmacother 2020;127:110181. [PMID: 32416561 DOI: 10.1016/j.biopha.2020.110181] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
12 Qu Z, Ren Y, Shen H, Wang H, Shi L, Tong D. Combination Therapy of Metastatic Castration-Recurrent Prostate Cancer: Hyaluronic Acid Decorated, Cabazitaxel-Prodrug and Orlistat Co-Loaded Nano-System. Drug Des Devel Ther 2021;15:3605-16. [PMID: 34447241 DOI: 10.2147/DDDT.S306684] [Reference Citation Analysis]
13 Fu Q, Wang J, Liu H. Chemo-immune synergetic therapy of esophageal carcinoma: trastuzumab modified, cisplatin and fluorouracil co-delivered lipid-polymer hybrid nanoparticles. Drug Deliv 2020;27:1535-43. [PMID: 33118428 DOI: 10.1080/10717544.2020.1837294] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
14 Bao H, Zheng N, Li Z, Zhi Y. Synergistic Effect of Tangeretin and Atorvastatin for Colon Cancer Combination Therapy: Targeted Delivery of These Dual Drugs Using RGD Peptide Decorated Nanocarriers. Drug Des Devel Ther 2020;14:3057-68. [PMID: 32801644 DOI: 10.2147/DDDT.S256636] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Yin N, Yu H, Zhang X, Lv X. Enhancement of Pancreatic Cancer Therapy Efficacy by Type-1 Matrix Metalloproteinase-Functionalized Nanoparticles for the Selective Delivery of Gemcitabine and Erlotinib. Drug Des Devel Ther 2020;14:4465-75. [PMID: 33122890 DOI: 10.2147/DDDT.S270303] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Wang J, Zhang S, Di L. Acute myocardial infarction therapy: in vitro and in vivo evaluation of atrial natriuretic peptide and triphenylphosphonium dual ligands modified, baicalin-loaded nanoparticulate system. Drug Deliv 2021;28:2198-204. [PMID: 34662253 DOI: 10.1080/10717544.2021.1989086] [Reference Citation Analysis]